MedImmune

Showing 6 posts of 51 posts found.

AstraZeneca takes $445m hit to halt motavizumab

December 22, 2010
Research and Development AZ, AstraZeneca, MedImmune, motavizumab, respiratory, respiratory syncytial virus

AstraZeneca has withdrawn a US licence application for its biologic respiratory treatment motavizumab in a move that will cost the …

Pfizer establishes new US research network

November 17, 2010
Research and Development, Sales and Marketing BiodiscoveryTherapeutics, MedImmune, Pfizer

Pfizer has established a new network of research partnerships with its Global Centers for Therapeutic Innovation. The Centers is a …

MedImmune Ventures appoints Ron Laufer

June 18, 2010
Research and Development AstraZeneca, MedImmune, appointment, research and development

Ron Laufer has joined MedImmune’s venture capital arm as senior managing director. The company, which is the worldwide biologics unit …

MedImmune: building a biologics future

April 19, 2010
Research and Development MedImmune, biologics

I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …

MedImmune broadens drug discovery in Cambridge

November 13, 2008
Research and Development Cambridge, MedImmune

MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …

MedImmune opens new R&D facility in Cambridge

October 17, 2008
Research and Development Cambridge, MedImmune

MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …

The Gateway to Local Adoption Series

Latest content